MVIR:STO
Medivir AB
1,51 SEK
arrow_upward
+0,80%(+0,012) 1D
12 հոկ, 17:29:47 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
1,49 SEK
High
1,51 SEK
Low
1,46 SEK
Mkt. cap
942,54 մլն
Avg. vol.
1,45 մլն
Volume
1,55 մլն
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 մլն
No. of employees
6
Open
1,49 SEK
High
1,51 SEK
Low
1,46 SEK
Mkt. cap
942,54 մլն
Avg. vol.
1,45 մլն
Volume
1,55 մլն
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 մլն
No. of employees
6
News stories
From web sources and news partners
Yahoo Finance
·
39 րոպե առաջ
Big Banks Kick Off Q3 Earnings With S&P 500 Near Records — Strategists Flag What Could Move Markets
Cryptonews.net
·
30 րոպե առաջ
Evernorth Hits Nasdaq With 473 Million XRP as XRPN Trading Begins
TipRanks
·
1 ժամ առաջ
Hyundai Motor Securities Prices S&P 500-Linked Bond, Raises KRW 8.24 Billion
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB